Proteomic Identification and Time-Course Monitoring of Secreted Proteins During Expansion of Human Mesenchymal Stem/Stromal in Stirred-Tank Bioreactor

被引:19
|
作者
Mizukami, Amanda [1 ]
Thome, Carolina Hassibe [1 ,2 ]
Ferreira, Germano Aguiar [1 ,2 ]
Lanfredi, Guilherme Pauperio [2 ]
Covas, Dimas Tadeu [1 ]
Pitteri, Sharon J. [3 ]
Swiech, Kamilla [1 ,4 ]
Faca, Vitor Marcel [1 ,2 ]
机构
[1] Univ Sao Paulo, Fac Med Ribeirao Preto, Hemotherapy Ctr Ribeirao Preto, Ribeirao Preto, Brazil
[2] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biochem & Immunol, Ribeirao Preto, Brazil
[3] Stanford Univ, Dept Radiol, Canary Ctr Stanford Canc Early Detect, Sch Med, Stanford, CA 94305 USA
[4] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Dept Pharmaceut Sci, Ribeirao Preto, Brazil
来源
基金
巴西圣保罗研究基金会;
关键词
mesenchymal stem/stromal cells; umbilical cord matrix; secretome; bioreactors; proteomic analysis; mass spectrometry; STEM-CELLS; STROMAL CELLS; TGF-BETA; EXTRACELLULAR-MATRIX; STATISTICAL-MODEL; BONE REGENERATION; PROMOTES; GROWTH; DIFFERENTIATION; RESPONSES;
D O I
10.3389/fbioe.2019.00154
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The therapeutic potential of mesenchymal stem/stromal cells (MSC) is widely recognized for the treatment of several diseases, including acute graft-vs.-host disease (GVHD), hematological malignancies, cardiovascular, bone, and cartilage diseases. More recently, this therapeutic efficacy has been attributed to the bioactive molecules that these cells secrete (secretome), now being referred as medicinal signaling cells. This fact raises the opportunity of therapeutically using MSC-derived soluble factors rather than cells themselves, enabling their translation into the clinic. Indeed, many clinical trials are now studying the effects of MSC-secretome in the context of cell-free therapy. MSC secretome profile varies between donors, source, and culture conditions, making their therapeutic use very challenging. Therefore, identifying these soluble proteins and evaluating their production in a reproducible and scalable manner is even more relevant. In this work, we analyzed the global profile of proteins secreted by umbilical cord matrix (UCM) derived-MSC in static conditions by using mass spectrometry, enabling the identification of thousands of proteins. Afterwards, relevant proteins were chosen and monitored in the supernatant of a fully-controllable, closed and scalable system (bioreactor) by using multiple reaction monitoring (MRM) mass spectrometric technique in a time-dependent manner. The results showed that the majority of interesting proteins were enriched through time in culture, with the last day of culture being the ideal time for supernatant collection. The use of this regenerative "soup," which is frequently discarded, could represent a step toward a safe, robust and reproducible cell-free product to be used in the medical therapeutic field. The future use of chemically defined culture-media will certainly facilitate secretome production according to Good Manufacturing Practice (GMP) standards.
引用
收藏
页数:10
相关论文
共 13 条
  • [1] SCALABLE EXPANSION OF HUMAN MESENCHYMAL STEM CELLS IN STIRRED-TANK BIOREACTORS
    Dufey, V.
    Tacheny, A.
    Art, M.
    Schouwenberg, J.
    Becken, U.
    De Longueville, E.
    Sha, M.
    [J]. CYTOTHERAPY, 2017, 19 (05) : S87 - S87
  • [2] Culture of human mesenchymal stem cells on microcarriers in a 5 l stirred-tank bioreactor
    Qasim A. Rafiq
    Kathryn M. Brosnan
    Karen Coopman
    Alvin W. Nienow
    Christopher J. Hewitt
    [J]. Biotechnology Letters, 2013, 35 : 1233 - 1245
  • [3] Culture of human mesenchymal stem cells on microcarriers in a 5 l stirred-tank bioreactor
    Rafiq, Qasim A.
    Brosnan, Kathryn M.
    Coopman, Karen
    Nienow, Alvin W.
    Hewitt, Christopher J.
    [J]. BIOTECHNOLOGY LETTERS, 2013, 35 (08) : 1233 - 1245
  • [4] MICROCARRIER-BASED XENO-FREE EXPANSION OF HUMAN MESENCHYMAL STROMAL CELLS IN A SINGLE-USE STIRRED-TANK BIOREACTOR
    Splan, D.
    Ravindhar, J.
    Spruiel, A.
    Bayne, K.
    Szczypka, M. S.
    [J]. CYTOTHERAPY, 2018, 20 (05) : S51 - S51
  • [5] Microcarrier-Based Xeno-Free Expansion of Human Mesenchymal Stromal Cells in a Single-Use Stirred-Tank Bioreactor
    Splan, David
    [J]. MOLECULAR THERAPY, 2018, 26 (05) : 361 - 361
  • [6] Dynamic expansion of mesenchymal stem/stromal cells in a stirred tank bioreactor promotes the release of potent extracellular vesicles
    Barekzai, Jan
    Friedrich, Jonas
    Okpara, Maduwuike
    Refflinghaus, Laura
    Eckhardt, Dustin
    Czermak, Peter
    Salzig, Denise
    [J]. AIMS BIOENGINEERING, 2023, 10 (03): : 240 - 264
  • [7] Growth Kinetics of Human Mesenchymal Stem Cells in a 3-L Single-Use, Stirred-Tank Bioreactor
    Jing, Donghui
    Sunil, Neethu
    Punreddy, Sandhya
    Aysola, Manjula
    Kehoe, Daniel
    Murrel, Julie
    Rook, Martha
    Niss, Knut
    [J]. BIOPHARM INTERNATIONAL, 2013, 26 (04) : 28 - +
  • [8] Process development for expansion of human mesenchymal stromal cells in a 50 L single-use stirred tank bioreactor
    Lawson, Tristan
    Kehoe, Daniel E.
    Schnitzler, Aletta C.
    Rapiejko, Peter J.
    Der, Kara A.
    Philbrick, Kathryn
    Punreddy, Sandhya
    Rigby, Susan
    Smith, Robert
    Feng, Qiang
    Murrell, Julie R.
    Rook, Martha S.
    [J]. BIOCHEMICAL ENGINEERING JOURNAL, 2017, 120 : 49 - 62
  • [9] Identification of critical process parameters for expansion of clinical grade human Wharton's jelly-derived mesenchymal stromal cells in stirred-tank bioreactors
    Lopez-Fernandez, Alba
    Garcia-Gragera, Victor
    Lecina, Marti
    Vives, Joaquim
    [J]. BIOTECHNOLOGY JOURNAL, 2024, 19 (02)
  • [10] Multiphase mixing characteristics in a microcarrier-based stirred tank bioreactor suitable for human mesenchymal stem cell expansion
    Grein, Tanja A.
    Leber, Jasmin
    Blumenstock, Miriam
    Petry, Florian
    Weidner, Tobias
    Salzig, Denise
    Czermak, Peter
    [J]. PROCESS BIOCHEMISTRY, 2016, 51 (09) : 1109 - 1119